Cooley Represents BioMarin in $10 Million Acquisition of Zacharon
Palo Alto, Calif. – January 9, 2013 – Cooley LLP announced today that it represented BioMarin Pharmaceuticals Inc. in its acquisition of Zacharon Pharmaceuticals, a private biotechnology company based in San Diego. Under the terms of the agreement, BioMarin paid $10 million upfront for 100 percent of Zacharon's share capital with the potential to make additional payments.
The Cooley team was led by mergers & acquisitions partner Jennifer Fonner DiNucci and included partners Marya Postner, Renee Deming and Natasha Leskovsek; senior counsels Lois Voelz and Buff Miller; and associates Dan Espinoza, Robin Bennett, Eric Chow, Laura McDaniels and Michael Baker.
BioMarin announced the transaction here.
About Cooley LLP
Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, venture capital, clean energy, real estate and retail.
The firm has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.